Effect of Fluticasone and Salmeterol on Tracheal Responsiveness to Ovalbumin and Lung Inflammation, Administrated during and after Sensitization

Figure 4

Mean ± SEM of the percentages of eosinophils (a), neutrophils (b), lymphocytes (c), and monocytes (d) of lung lavage in control group and sensitized groups treated with fluticasone + salmeterol and placebo during (A), after (B), and during sensitization period and 18 days delay (C). Comparison of the data between control and three treated with fluticasone propionate + salmeterol and three placebo groups was done using one-way analysis of variance (ANOVA) with Tukey-Kramer posttest. ⁺: 𝑃<0.05, ⁺⁺: 𝑃<0.01, and ⁺⁺⁺: 𝑃<0.001. Comparison of the data between each treated group with fluticasone propionate + salmeterol and corresponding placebo group was done using unpaired 𝑡-test, NS: nonsignificant, *: 𝑃<0.05, ***: 𝑃<0.001, and NS: nonsignificant.

(a)

(b)

(c)

(d)